• Citations Per Year
Learn More
5517 Background: Gefitinib (G) has shown activity as a single agent in patients (pts) with advanced SSCHN, and a dose-response relationship has been observed. Skin toxicity has been postulated to be a predictor of response and improved outcome. The purpose of this study is to evaluate the activity of G when administered as single agent at a dose that(More)
OBJECTIVE To observe clinical therapeutic effect of acupuncture on diabetic paralytic squint. METHODS Seventy-two cases of diabetic paralytic squint were randomly divided into a medication group, an acupuncture group and an acupuncture and medication group. The medication group were treated with intramuscular injection of Methyl vitamin B12 250 microg,(More)
  • 1